Kantonsspital Olten, Switzerland Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
1999
NCT01637818
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

Department of Gastroenterology, Kantonsspital Olten, Switzerland | Kantonsspital Olten

Active Ingredients

Drugs in Phase 2 Trials (1)

budesonide (rhinocort) (1 trial)

Drugs in Other Trials (1)

acetaminophen (tylenol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eosinophilic Esophagitis (Phase 2)

Esophagitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2